TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Return on Sales [ROS] (2020 - 2026)

Updated

TScan Therapeutics (TCRX) reported Return on Sales [ROS] of -5636.69% for Q3 2026, down 4161.10 percentage points from -1475.59% a year earlier and down 2735.36 percentage points from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, TScan Therapeutics' Return on Sales [ROS] came in at -2246.84%, down 481.83 percentage points year-over-year; for FY2025, it came in at -1315.38%, up 3472.30 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of +1102.41 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at -4787.68% in FY2024 (-4343.68 pp), -444.00% in FY2023 (+48.32 pp), -492.32% in FY2022 (-12.68 pp) and -479.65% in FY2021 (+1938.14 pp).
  • The Q3 2026 figure ranks as the lowest quarterly Return on Sales [ROS] since Q2 2024.
  • Year over year, Return on Sales [ROS] has now declined in each of the last three quarters, with an average year-over-year change of +359.84 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q2 2025 (a gain of 5107.95 percentage points); the low point was Q2 2024 (a drop of 5582.79 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at -2901.33% (Q2 2026), -2967.31% (Q1 2026) and -929.41% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -907.40%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 34.46%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 24.35%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 36.01%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 30.74%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 41.71%
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - -5,636.69%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -5,636.69%
Jun 30, 2026 -2,901.33%
Mar 31, 2026 -2,967.31%
Dec 31, 2025 -929.41%
Sep 30, 2025 -1,475.59%
Jun 30, 2025 -1,256.60%
Mar 31, 2025 -1,669.74%
Dec 31, 2024 -5,520.60%
Sep 30, 2024 -3,109.82%
Jun 30, 2024 -6,364.55%
Mar 31, 2024 -5,542.93%
Dec 31, 2023 -296.17%
Sep 30, 2023 -636.69%
Jun 30, 2023 -781.77%
Mar 31, 2023 -334.31%
Dec 31, 2022 -602.55%
Sep 30, 2022 -492.95%
Jun 30, 2022 -375.89%
Mar 31, 2022 -535.02%
Dec 31, 2021 -497.62%
API Access

TScan Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TCRX&period=max&api_key=YOUR_API_KEY